Euthyrox N 100, 100 micrograms, tablets
Euthyrox N 150, 150 micrograms, tablets
Euthyrox N 200, 200 micrograms, tablets
Sodium levothyroxine
Sodium levothyroxine, the active substance of Euthyrox N, is a synthetic thyroid hormone
intended for the treatment of thyroid diseases and disorders.
It has the same effect as the thyroid hormones that occur naturally in the body.
Euthyrox N 100; Euthyrox N 150 and Euthyrox N 200 are used:
Euthyrox N 100 is also used to adjust thyroid hormone levels in patients
who are taking antithyroid drugs due to excessive thyroid hormone production.
Euthyrox N 100, Euthyrox N 150 and Euthyrox N 200 may also be used in tests evaluating
thyroid function.
Before starting treatment with this medicine, you should inform your doctor about the following diseases:
Before starting treatment with Euthyrox N, you should tell your doctor if you have adrenal insufficiency.
Your doctor will perform the necessary tests to determine if you have adrenal or pituitary disorders or a certain type of thyroid disorder with uncontrolled excess thyroid hormone production (autonomous thyroid function), as in such cases, appropriate treatment may be necessary before starting Euthyrox N.
When starting treatment with levothyroxine in premature infants with very low birth weight, blood pressure should be regularly monitored, as a sudden drop in blood pressure (so-called circulatory collapse) may occur.
In the event of a change of medication to another levothyroxine-containing medication, a disruption of thyroid hormone balance may occur. You should consult your doctor if you have any questions about changing medications. During the transition period, close monitoring of clinical and biochemical parameters is necessary. You should inform your doctor if you experience any side effects, as it may be necessary to increase or decrease the dose.
Thyroid hormones are not used to reduce weight. Taking them will not lead to weight loss if thyroid hormones are maintained at the proper level. Increasing the dose of the medicine without consulting a doctor can lead to serious and life-threatening side effects. You should not take high doses of levothyroxine in combination with other weight loss medications, such as amfepramone, catherine, and phenylpropanolamine, due to the possible increased risk of serious and life-threatening side effects.
You should discuss with your doctor:
You should inform your doctor about all medications you are currently taking or have recently taken, as well as any medications you plan to take.
If you are taking any of the following medications, you should inform your doctor, as Euthyrox N may affect the action of these medications:
In the event of concurrent use of the following medications with Euthyrox N, you should strictly follow the recommended time intervals between taking the respective medications:
If you are taking any of the following medications, you should inform your doctor, as they may weaken the action of Euthyrox N:
and herbal preparations containing St. John's Wort (some herbal medications).
If you are taking any of the following medications, you should inform your doctor, as they may enhance the action of Euthyrox N:
In the event of taking orlistat, you should inform your doctor. Concurrent use of Euthyrox N and orlistat may lead to hypothyroidism and (or) worsening of hypothyroidism control.
If you are taking protease inhibitors (medications used to treat HIV infection, such as ritonavir, indinavir, lopinavir) or phenytoin (an antiepileptic medication), which may affect the action of Euthyrox N, you should inform your doctor.
In this case, it may be necessary to perform thyroid hormone tests and adjust the dose of Euthyrox N.
If you are taking amiodarone (a medication used to treat heart rhythm disorders), you should inform your doctor, as this medication may affect thyroid function.
You should inform your doctor about taking Euthyrox N if diagnostic tests using iodine-containing contrast agents are necessary, as these tests may affect thyroid function.
If you are currently taking or have recently taken biotin, you must inform your doctor or laboratory staff if thyroid hormone laboratory tests are to be performed. Biotin may affect laboratory test results (see "Warnings and precautions").
If your diet includes soy products, you should inform your doctor, especially if you change the amount of these products you consume. Soy products may reduce the absorption of Euthyrox N from the small intestine, and therefore, it may be necessary to adjust the dose of Euthyrox N.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before taking this medicine.
During pregnancy, you should continue taking Euthyrox N under medical supervision, as it may be necessary to adjust the dose of the medicine.
If Euthyrox N was taken concurrently with an antithyroid medication for the treatment of excessive thyroid hormone production, your doctor will recommend that you stop taking Euthyrox N after becoming pregnant.
During pregnancy, you should not take antithyroid medications concurrently.
During pregnancy, you should not undergo diagnostic tests that involve suppressing thyroid function.
During breastfeeding, you should continue taking Euthyrox N as recommended by your doctor. The amount of levothyroxine that passes into breast milk is too small to affect the baby.
No studies have been conducted on the effect of the medicine on the ability to drive and use machines. It is not expected that Euthyrox N will have any effect on the ability to drive and use machines when used as recommended, as levothyroxine is identical to the form that occurs naturally.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means that the medicine is considered "sodium-free".
This medicine should always be taken as directed by your doctor. If you are unsure, consult your doctor or pharmacist.
Your doctor will determine the appropriate dose for each patient individually, based on clinical evaluation and laboratory tests. Treatment usually starts with a small dose, which is increased every 2-4 weeks until the full dose, adjusted individually for each patient, is reached.
In the first few weeks of treatment, laboratory tests will be necessary to allow your doctor to adjust the appropriate dose.
Typical dose ranges are presented in the table below. Lower doses may be sufficient for:
Use of Euthyrox N | Recommended daily dose of sodium levothyroxine |
in the treatment of goiter in patients with normal thyroid function |
|
to prevent goiter recurrence after surgery |
|
to supplement the deficiency of natural thyroid hormones in adults, when their production by the thyroid gland is insufficient
|
|
to supplement the deficiency of natural thyroid hormones in children and adolescents, when their production by the thyroid gland is insufficient
| 12.5 – 50 micrograms
|
to inhibit tumor growth in patients with thyroid cancer |
|
to adjust thyroid hormone levels during treatment of excessive thyroid hormone production with antithyroid medications |
|
in tests evaluating thyroid function | Euthyrox N 100: |
In newborns and infants with congenital hypothyroidism, characterized by insufficient thyroid hormone production, for whom rapid supplementation is essential, the recommended initial dose is 10 to 15 micrograms/kg body weight per day for the first 3 months. Then, your doctor will adjust the dose individually based on clinical evaluation and thyroid hormone and TSH levels.
Method of administration
Euthyrox N is intended for oral use.
The single daily dose should be taken in the morning, on an empty stomach (at least half an hour before breakfast), preferably with a small amount of liquid, e.g., half a glass of water.
Infants should be given the entire daily dose of Euthyrox N at one time, at least half an hour before the first meal of the day. Immediately before administration, the tablet should be crushed and mixed with a small amount of water. The resulting suspension should be given with an additional small amount of liquid.
A new suspension of the medicine should be prepared each time before administration.
Duration of treatment
The duration of treatment may vary depending on the reason for which Euthyrox N is used. Your doctor will discuss with you individually how long you should take the medicine.
Most patients need to take Euthyrox N for the rest of their lives.
In the event of a dose change, your doctor may recommend Euthyrox N with a different strength.
In the event of taking a higher dose than recommended, the following symptoms may occur: rapid heartbeat, anxiety, agitation, or involuntary movements. In patients with neurological disorders, such as epilepsy, single seizures have been observed.
Overdose may cause hyperthyroidism and lead to symptoms of acute psychosis.
In such cases, you should consult a doctor.
You should not take a double dose to make up for a missed dose. The next day, take the usual dose of the medicine.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Euthyrox N can cause side effects, although not everybody gets them.
Euthyrox N is identical to the natural thyroid hormone. Therefore, if Euthyrox N is taken in the dose recommended by your doctor and if regular laboratory tests are performed, side effects should not occur.
2 tablets per day 1 or 2 weeks before the test Euthyrox N 150: 1/2 tablet per day 3 or 4 weeks before the test 1 tablet per day 1 or 2 weeks before the test Euthyrox N 200: 1 tablet per day 1 or 2 weeks before the test |
You should stop taking the medicine and consult your doctor immediately if you experience sudden symptoms of hypersensitivity to the ingredients of Euthyrox N: facial swelling, tongue or throat swelling, difficulty swallowing, difficulty breathing (angioedema); respiratory reactions (increasing shortness of breath); skin reactions (rash, urticaria). The frequency of these side effects is unknown.
In the event of taking a higher dose of Euthyrox N than recommended or poor tolerance of the recommended dose (e.g., rapid dose increase), some of the following side effects may occur: irregular or rapid heart rhythm, palpitations, chest pain, headache, weakness or muscle cramps, hot flashes (feeling of heat and facial flushing), fever, vomiting, menstrual disorders, pseudotumor cerebri (increased intracranial pressure), tremors, restlessness, sleep disturbances, sweating, weight loss, diarrhea.
If you experience any of the above symptoms, you should contact your doctor.
Your doctor may decide to interrupt treatment for a few days or reduce the daily dose until the symptoms disappear.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Medicinal Product Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: +48 22 49 21 301
fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Do not use Euthyrox N after the expiry date stated on the blister or carton after "EXP". The expiry date refers to the last day of the month.
Do not store above 25°C.
To protect from light, store the blister in the outer packaging.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Euthyrox N tablets are white, round, flat, with a dividing line on both sides, with beveled edges, and an inscription on one side:
Euthyrox N 100: EM 100
Euthyrox N 150: EM 150
Euthyrox N 200: EM 200
The tablet can be divided into equal doses.
Euthyrox N is available in packs containing 50 or 100 tablets in a carton.
Not all pack sizes may be marketed.
Merck Sp. z o.o.
Al. Jerozolimskie 142B
02-305 Warsaw, Poland
tel. +48 22 53 59 700
Logo of the marketing authorization holder
Merck Healthcare KGaA
Frankfurter Strasse 250
64293 Darmstadt, Germany
FAMAR HEALTH CARE SERVICES MADRID, S.A.U.
Avda. Leganés, 62
Alcorcón, 28923 Madrid, Spain
Merck Healthcare KGaA
Frankfurter Strasse 250
64293 Darmstadt, Germany
Date of last revision of the leaflet:
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.